In a significant move, hospitals in New York City have decided to sever ties with Palantir, a company often surrounded by controversy due to its AI-driven technologies. This decision comes amidst Palantir's expansion efforts in the UK, where it is seeking to broaden its influence in healthcare and other sectors. Critics have raised concerns about privacy and ethical implications surrounding the use of Palantir's tools. As the company navigates these challenges and aims for growth across the Atlantic, the decision of NYC hospitals highlights the ongoing debate over the role of AI in healthcare and the responsibilities of tech firms in safeguarding patient data.